In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea

Biomedicine and Pharmacotherapy

Volumn 61, Issue 10, 2007, Pages 693-697

  Aguilar Hernández, Montserrat ^a   Méndez, José D ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Advanced glycation end products; Aminophospholipids; Glycylglycine; Ketoacidosis; Ketone bodies; Urea

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ACETONE; ADVANCED GLYCATION END PRODUCT; AMINOPHOSPHOLIPID; CHLOROFORM; GLUCOSE; GLYCYLGLYCINE; KETONE BODY; METHANOL; UREA; WATER;

ABSORPTION; AMINOPHOSPHOLIPID GLYCATION; ARTICLE; BRAIN; GLYCATION; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ACETOACETATES; ANIMALS; BRAIN CHEMISTRY; CATTLE; CHROMATOGRAPHY, THIN LAYER; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYCYLGLYCINE; KETONE BODIES; LIPIDS; PHOSPHOLIPIDS; SPECTROPHOTOMETRY, ULTRAVIOLET; UREA;

EID: 36849065364     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.06.004     Document Type: Article

References (24)

1. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 124 1 (1994) 19-30
2. Brownlee M., Cerami A., and Vlassara H. Advanced glycation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
3. Brownlee M., Vlassara H., and Cerami A. The pathogenetic role of nonenzymatic glycosylation in diabetic complications. In: Crabbe M.J.C. (Ed). Diabetic complications: scientific and clinical aspects (1987), Churchill Livingston, London 94
4. Bucala R., Vlassara H., and Cerami A. Advanced glycosylation end products. In: Harding J.J., and Crabbe M.J.C. (Eds). Post-translational modifications of proteins (1992), CRC Press Inc., Boca Raton, Florida 53-79
5. Beisswenger P.J., Moore L.L., Brinck-Johnsen T., and Curphey T.J. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92 1 (1993) 212-217
6. Dyer D.G., Blackledge J.A., Thorpe S.R., and Baynes J.W. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol Chem 266 18 (1991) 11654-11660
7. Odetti P., Fogarty J., Sell D.R., and Monnier V.M. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41 2 (1992) 153-159
8. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., and Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 87 22 (1990) 9010-9014
9. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267 21 (1992) 14998-15004
10. Skolnik E.Y., Yang Z., Makita Z., Radoff S., Kirstein M., and Vlassara H. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174 4 (1991) 931-939
11. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 4 (1991) 405-412
12. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 13 (1994) 9889-9897
13. Gerich J.E., Lorenzi M., Bier D.M., Tsalikian E., Schneider V., Karam J.H., et al. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism: studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest 57 (1976) 875-884
14. McGarry J.D. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 5 (1989) 271-284
15. Xie J., García-Pérez E., and Méndez J.D. In vitro glycation of hemoglobin by acetone and β-hydroxybutyrate. World Appl Sci J 1 2 (2007) 99-106
16. Taguchi T., Sugiura M., Hamada Y., and Miwa I. Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal. Eur J Pharmacol 378 3 (1999) 283-289
17. Booth A.A., Khalifah R.G., and Hudson B.G. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. Biochem Biophys Res Commun 220 1 (1996) 113-119
18. Nogowsky L., and Nowak K.W. Arginine, administered in various ways, as a stimulator of insulin secretion in the rabbit. Horm Metab Res 18 (1986) 730-733
19. Tsopanoglou N.E., Zioudrou C., Tsilibary E.C., and Charonis A.S. Putrescine: a novel inhibitor of glycosylation-induced cross-links in laminin. Microcirculation 2 3 (1995) 283-287
20. Méndez J.D., Xie J., and García-Pérez E. Urea inhibits the in vitro formation of fluorescent advanced glycation end products. World Appl Sci J 2 2 (2007) 90-98
21. Méndez J.D. Aislamiento de Lípidos. In: Méndez J.D. (Ed). Experimentos Básicos de Bioquímica (2001), Ed. Prado 92-95
22. Bruer J., Chung K.J., Pesonen E., Haas R.H., Guth B.D., Sahn D.J., et al. Ketone bodies maintain normal cardiac function and myocardial high energy phosphates during insulin-induced hypoglycemia in vivo. Basic Res Cardiol 84 5 (1989) 510-523
23. Bucala R., Makita Z., Koschinsky T., Cerami A., and Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A 90 14 (1993) 6434-6438
24. Hoberman H.D., and Stone D. On the metabolism of glycylglycine. J Biol Chem 194 11 (1952) 383-391